Get In Touch

Global Cancer Pain Management Market: Snapshot

The global cancer pain management market is envisaged to gain a telling impetus while riding on the moderate to severe pattern of pain experienced by patients worldwide. Nearly a 70.0% of cancer patients could suffer from chronic pain because of spinal cord injuries, 28.0% due to multiple sclerosis, and 8.0% on account of stroke on a global platform. Besides this, an above 75.0% of the patients are expected to complain of a gradual surge in pain with the progression of the disease. Increase in the count of patients experiencing such pain could put a positive effect on the growth of the market.

With elevating research and development focus, there could be a range of drugs in the pipeline. This is anticipated to bode well for the global cancer pain management market as more drugs could mean a rise in demand.

From the geographical perspective, the global cancer pain management market is prognosticated to be segregated into key regions, out of which, North America could take a leading position. Better healthcare spending, improved healthcare infrastructure, and presence of leading players are some of the top reasons that the region is predicted to outclass other geographical segments of the market. However, Asia Pacific could make its presence known for cancer pain management on the back of enhanced healthcare services provided to patients and key countries such as India, Brazil, and China exhibiting multiplied investments by their governments. Growing awareness about cancer and its pain management could also contribute to the growth of Asia Pacific.

Pain is an unpleasant emotional, subjective, and sensory experience due to the actual or potential damage caused to cells or tissues of the patients. Pain is the most common symptom in various manifestations that lead patients to seek medical assistance or advice. Cancer is associated with several well-defined acute as well as chronic pain syndromes. Cancer is a complex and potentially fatal disease that is primarily caused through environmental factors resulting into gene mutations affecting critical cell-regulatory proteins. Such changes trigger aberrant cell behavior leading to uncontrolled proliferation of cells (tumor formation) and subsequent destruction of surrounding normal tissues. Tumors are either benign or malignant, while the malignant tumors are characterized by rapid growth, invasiveness, and potential to colonize in distant organs. These tumors exert pressure by pressing on nerves, bones, and other parts of the body causing pain. Cancer pain is also experienced during active cancer therapy and primarily during the advanced stages of cancer.

The rising prevalence of cancer across the globe is driving the global cancer diagnostics market. According to the International Agency for Research on Cancer, there were 14.1 million new cases of cancer and 8.2 million deaths recorded globally in 2012. Based on the above statistical information, the World Health Organization (WHO) estimated that by 2025, 19.3 million new cases are expected to occur each year. Rising incidences of cancer and increasing healthcare spending is anticipated to aid the global cancer pain management market. Moreover, the Patient Protection Act and Affordable Care Act amended on March 30, 2010, by the Health Care and Education Reconciliation Act, enhancing the insurance access to more than 25 million U.S. citizens, is eventually estimated to support the growth of cancer pain management.

The pain management methods for cancer used currently, include medication or drugs, nerve blocks, oral morphine therapy, fentanyl patches, and medical systems or devices. Opioids are considered to be the most effective way of pain management, while combined pain management therapies and medication are more effective. The global market for cancer pain management is projected to expand significantly due to advances in technology for better alternatives for pain management and favorable government initiatives and funding. The alarming rise in the rate of cancer prevalence compels healthcare providers to rethink of their goals of treating cancer and also focus on pain management, which is likely to require cancer pain management methods that are specific, efficient, and sensitive. The cancer pain management market can be segmented into treatment type, disease indication, and regions, which is as follows:

By treatment type, the cancer pain management market can be segmented into:

  • Medications
    • Opioids/Narcotics
      • Morphine
      • Fentanyl
      • Others
    • Non-Opioids
      • Acetaminophen
      • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    • Nerve Blocks
  • Devices or Systems
    • Electrical Stimulation Devices
      • Transcutaneous Electrical Nerve Stimulation (TENS) Devices
      • Neuromuscular Electrical Stimulation (NMES/EMS) Devices
      • Others (Electrotherapy Devices, Combination Devices, etc.)
    • Analgesic Infusion Pumps
      • Intrathecal Infusion Pumps
      • External Infusion Pumps
    • Neurostimulation Devices
      • Spinal Cord Stimulation (SCS) Devices
      • Deep Brain Stimulation Devices
      • Others
    • Radiofrequency Ablation Devices

By disease indication, the cancer pain management market can be segmented into:

  • Lung Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Blood Cancer
  • Others

In terms of regions, the cancer pain management market can be into Asia Pacific (APAC), Europe, Middle East & Africa (MEA), North America (NA), and Latin America (LA). Key players operating in the cancer pain management market include Abbott, Boston Scientific Corporation, Baxter, Medtronic plc., and Olympus. Intense competition is driving acquisition and in-licensing agreements, as companies are striving to expand and diversify their product pipeline. Strategic partnership and alliances are commonplace, as companies are aiming to synergize their programs and develop combination pain management therapies.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Cancer Pain Management Market

Pre Book